Skip to main content

Table 2 Differences in individual factors between those who were aware of the Nagahama study and those who knew nothing about the Nagahama study from Qui-square test

From: Experiences and attitudes of residents regarding a community-based genome cohort study in Japan: a population-based, cross-sectional study

  Male (n=704) Female (n=769)
Aware of the Nagahama study (n=210) % Know nothing (n=483) % OR 95 % CI P-value Aware of the Nagahama study (n=381) % Know nothing (n=376) % OR 95 % CI P-value
Age group years)
 30–39 25.2 74.8 1    40.3 59.7 1   
 40–49 20.9 79.1 0.78 0.43–1.41 0.415 43.7 56.3 1.15 0.74–1.78 0.527
 50–59 26.8 73.2 1.09 0.63–1.88 0.767 57.9 42.1 2.04 1.33–3.12 0.001
 60–69 38.6 61.4 1.86 1.14–3.05 0.013 55.9 44.1 1.89 1.25–2.84 0.003
Formal education period
 High school graduate and 30.4 69.6 1    47.9 52.1 1   
 College and higher 31.1 68.9 0.97 0.69–1.35 0.844 53.9 46.1 0.79 0.59–1.06 0.109
Self-rated understanding of terminology
 High 37.3 62.7 1    62.8 37.2 1   
 Middle 30.7 69.3 0.74 0.51–1.08 0.122 51.5 48.5 0.63 0.43–0.92 0.018
 Low 21.1 78.9 0.45 0.29–0.69 <0.001 41.6 58.4 0.42 0.29–0.62 <0.001
Awareness of benefits
 Helpful for disease diagnosis 91.1 79.0 2.73 1.60–4.66 <0.001 90.2 77.0 2.76 1.80–4.23 <0.001
 Helpful for disease treatment 93.2 78.3 3.77 2.10–6.78 <0.001 89.1 76.5 2.51 1.66–3.79 <0.001
 Helpful for disease prevention 90.2 75.7 2.96 1.78–4.92 <0.001 89.1 77.0 2.44 1.61–3.70 <0.001
Concerns
 Financial infusion 79.7 77.7 1.13 0.75–1.69 0.572 78.7 74.4 1.27 0.90–1.80 0.180
 Privacy concerns 57.7 61.7 0.85 0.61–1.19 0.339 56.3 52.8 1.15 0.86–1.55 0.355
 Discriminations 40.4 45.0 0.83 0.59–1.16 0.275 38.5 37.2 1.06 0.78–1.44 0.711
 Unexpected negative effects 34.0 42.8 0.68 0.49–0.97 0.034 30.5 32.6 0.91 0.66–1.25 0.564
 Cloned human beings 33.5 37.0 0.86 0.61–1.22 0.387 29.0 32.0 0.87 0.63–1.20 0.391
Belief
 Company or government bodies use genome information 44.5 45.6 0.96 0.69–1.34 0.796 39.9 38.8 1.05 0.78–1.42 0.758